Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,700 | 77,300 | 63,700 | 21,100 | 16,400 |
| Depreciation Amortization | 53,700 | 226,200 | 172,700 | 117,500 | 59,600 |
| Income taxes - deferred | -12,900 | -7,500 | -31,300 | -12,400 | -6,200 |
| Accounts receivable | 64,100 | -21,400 | 52,000 | -1,600 | 46,800 |
| Accounts payable and accrued liabilities | -41,200 | -36,100 | -94,200 | -21,800 | -42,300 |
| Other Working Capital | -9,500 | -51,000 | -97,900 | -47,500 | -10,600 |
| Other Operating Activity | 11,700 | 71,900 | 49,500 | 71,300 | 14,200 |
| Operating Cash Flow | $42,200 | $259,400 | $114,500 | $126,600 | $77,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19,600 | -63,700 | -37,500 | -33,800 | -21,000 |
| Net Acquisitions | -9,100 | -84,900 | -84,800 | -84,800 | -29,600 |
| Sale Of Investment | N/A | 66,000 | 66,000 | N/A | N/A |
| Other Investing Activity | -100 | -100 | -100 | -100 | -100 |
| Investing Cash Flow | $-28,800 | $-82,700 | $-56,400 | $-118,700 | $-50,700 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 261,300 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 275,000 | 275,000 | N/A | N/A |
| Debt Repayment | -243,400 | -209,300 | -125,600 | -23,100 | -5,500 |
| Common Stock Issued | 0 | 800 | 700 | 700 | 500 |
| Common Stock Repurchased | -1,200 | -900 | -900 | -900 | -900 |
| Dividend Paid | -32,500 | -327,100 | -83,300 | -55,500 | -27,800 |
| Other Financing Activity | -80,700 | -38,000 | -38,100 | -32,100 | 0 |
| Financing Cash Flow | $-96,500 | $-299,500 | $27,800 | $-110,900 | $-33,700 |
| Beginning Cash Position | 205,300 | 328,100 | 328,100 | 328,100 | 328,100 |
| End Cash Position | 122,200 | 205,300 | 414,000 | 225,100 | 321,600 |
| Net Cash Flow | $-83,100 | $-122,800 | $85,900 | $-103,000 | $-6,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 42,200 | 259,400 | 114,500 | 126,600 | 77,900 |
| Capital Expenditure | -21,000 | -98,400 | -69,800 | -54,200 | -21,100 |
| Free Cash Flow | 21,200 | 161,000 | 44,700 | 72,400 | 56,800 |